• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国慢加急性肝衰竭:建立患者登记系统的理由和基线特征。

Acute-on-Chronic Liver Failure in China: Rationale for Developing a Patient Registry and Baseline Characteristics.

机构信息

Department of Gastroenterology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Shanghai Institute of Digestive Disease, Shanghai, China.

出版信息

Am J Epidemiol. 2018 Sep 1;187(9):1829-1839. doi: 10.1093/aje/kwy083.

DOI:10.1093/aje/kwy083
PMID:29762630
Abstract

Definitions and descriptions of acute-on-chronic liver failure (ACLF) vary between Western and Eastern types, and alcoholism and hepatitis B virus (HBV) are, respectively, the main etiologies. To determine whether there are unified diagnostic criteria and common treatment programs for different etiologies of ACLF, a multicenter prospective cohort with the same inclusion criteria and disease indicators as those used in the European Consortium Acute-on-Chronic Liver Failure in Cirrhosis Study is urgently needed in Asia, where the prevalence of HBV is high. A multicenter prospective cohort of 2,600 patients was designed, drawing from 14 nationwide liver centers from tertiary university hospitals in China, and 2,600 hospitalized patients with chronic liver disease (both cirrhotic and noncirrhotic) of various etiologies with acute decompensation or acute hepatic injury were continuously recruited from January 2015 to December 2016. Data were collected during hospitalization, and follow-ups were performed once a month, with plans to follow all patients until 36 months after hospital discharge. Of these patients, 1,859 (71.5%) had HBV-related disease, 1,833 had cirrhotic disease, and 767 had noncirrhotic disease. The numbers and proportions of enrolled patients from each participating center and the baseline characteristics of the patients with or without cirrhosis are presented.

摘要

定义和描述的急性肝衰竭(ACLF)之间的西方和东方类型的不同,和酒精中毒和乙型肝炎病毒(HBV)分别是主要病因。为了确定是否有统一的诊断标准和共同的治疗方案为不同病因的 ACLF,多中心前瞻性队列与相同的纳入标准和疾病指标用于欧洲联盟急性肝衰竭在肝硬化研究中是迫切需要在亚洲,乙型肝炎病毒(HBV)的流行率高。多中心前瞻性队列的 2600 例患者,从中国的 14 个全国性的肝脏中心从大学医院的三级设计,和 2600 例住院的慢性肝脏疾病(肝硬化和非肝硬化)与急性失代偿或急性肝损伤不断招募从 2015 年 1 月到 2016 年 12 月。数据收集在住院期间,并进行每月一次的随访,计划随访所有患者直到出院后 36 个月。这些患者中,有 1859 例(71.5%)与 HBV 相关疾病,1833 例有肝硬化,767 例非肝硬化。从每个参与中心的患者人数和比例和基线特征的患者有或没有肝硬化。

相似文献

1
Acute-on-Chronic Liver Failure in China: Rationale for Developing a Patient Registry and Baseline Characteristics.中国慢加急性肝衰竭:建立患者登记系统的理由和基线特征。
Am J Epidemiol. 2018 Sep 1;187(9):1829-1839. doi: 10.1093/aje/kwy083.
2
Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure.乙型肝炎病毒相关慢加急性肝衰竭诊断标准和预后评分的制定。
Gut. 2018 Dec;67(12):2181-2191. doi: 10.1136/gutjnl-2017-314641. Epub 2017 Sep 19.
3
Risk of different precipitating events for progressing to acute-on-chronic liver failure in HBV-related cirrhotic patients.乙肝相关肝硬化患者进展为慢加急性肝衰竭的不同诱发事件风险。
J Dig Dis. 2017 May;18(5):292-301. doi: 10.1111/1751-2980.12480.
4
Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.慢性肝衰竭联盟急性加重慢性肝衰竭和急性失代偿评分可预测巴西肝硬化患者的死亡率。
World J Gastroenterol. 2017 Jul 28;23(28):5237-5245. doi: 10.3748/wjg.v23.i28.5237.
5
Acute-on-chronic liver failure exists in patients with hepatitis B virus-related decompensated cirrhosis.急性加重的慢性肝衰竭存在于乙型肝炎病毒相关失代偿性肝硬化患者中。
J Dig Dis. 2018 Oct;19(10):614-625. doi: 10.1111/1751-2980.12671.
6
Cohort profile: a multicentre prospective validation cohort of the Chinese Acute-on-Chronic Liver Failure (CATCH-LIFE) study.队列特征描述:一项中国慢加急性肝衰竭(CATCH-LIFE)研究的多中心前瞻性验证队列研究。
BMJ Open. 2021 Jan 8;11(1):e037793. doi: 10.1136/bmjopen-2020-037793.
7
Is HBV viral load at admission associated with development of acute-on-chronic liver failure in patients with acute decompensation of chronic hepatitis B related cirrhosis?入院时 HBV 病毒载量与慢性乙型肝炎相关肝硬化急性失代偿患者发生慢加急性肝衰竭的关系
BMC Infect Dis. 2019 Apr 30;19(1):363. doi: 10.1186/s12879-019-3988-1.
8
Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition.慢加急性肝衰竭的特征与差异:需要统一的定义
PLoS One. 2016 Jan 20;11(1):e0146745. doi: 10.1371/journal.pone.0146745. eCollection 2016.
9
Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis.肝硬化门诊患者慢加急性肝衰竭的发生率、预测因素和结局。
J Hepatol. 2017 Dec;67(6):1177-1184. doi: 10.1016/j.jhep.2017.07.008. Epub 2017 Jul 19.
10
Submassive hepatic necrosis distinguishes HBV-associated acute on chronic liver failure from cirrhotic patients with acute decompensation.亚大块肝坏死可将 HBV 相关慢加急性肝衰竭与肝硬化急性失代偿患者区分开来。
J Hepatol. 2015 Jul;63(1):50-9. doi: 10.1016/j.jhep.2015.01.029. Epub 2015 Jan 31.

引用本文的文献

1
Acute versus acute-on-chronic liver failure: comparative analysis of clinical outcomes in Beijing, China.急性肝衰竭与慢加急性肝衰竭:中国北京临床结局的比较分析
BMC Gastroenterol. 2025 Sep 3;25(1):637. doi: 10.1186/s12876-025-04234-x.
2
Novel and simplified model for the precise identification of concurrent bacterial infections in patients aged 60 years and older with acute-on-chronic liver diseases: a nationwide, multicentre, prospective cohort study.用于精准识别60岁及以上慢性肝病急性发作患者并发细菌感染的新型简化模型:一项全国性、多中心、前瞻性队列研究。
Hepatol Int. 2025 Jul 28. doi: 10.1007/s12072-025-10855-x.
3
Anti-HBc IgM associates with acute flare and HBeAg/HBsAg loss in chronic hepatitis B patients with acute exacerbation.
抗-HBc IgM与慢性乙型肝炎急性加重患者的急性发作及HBeAg/HBsAg消失相关。
Virulence. 2025 Dec;16(1):2534078. doi: 10.1080/21505594.2025.2534078. Epub 2025 Jul 17.
4
Evidence-based incorporation of key parameters into MELD score for acute-on-chronic liver failure.基于证据将关键参数纳入慢性重型肝炎的终末期肝病模型评分。
eGastroenterology. 2024 Oct 1;2(3):e100101. doi: 10.1136/egastro-2024-100101. eCollection 2024 Sep.
5
Nomograms for predicting short-term mortality in acute-on-chronic liver disease caused by the combination of hepatitis B virus and alcohol.用于预测乙型肝炎病毒和酒精引起的慢加急性肝衰竭患者短期死亡率的列线图。
Sci Rep. 2024 Oct 19;14(1):24578. doi: 10.1038/s41598-024-76473-z.
6
Association of AST/ALT ratio with 90-day outcomes in patients with acute exacerbation of chronic liver disease: a prospective multicenter cohort study in China.慢性肝病急性加重患者谷草转氨酶/谷丙转氨酶比值与90天预后的关联:一项中国前瞻性多中心队列研究
Front Med (Lausanne). 2024 Mar 21;11:1307901. doi: 10.3389/fmed.2024.1307901. eCollection 2024.
7
A clinical study of non-bioartificial liver DPMAES support system in hepatitis B-related acute-on-chronic liver failure.乙型肝炎相关性慢加急性肝衰竭的非生物人工肝 DPMAES 支持系统的临床研究。
Sci Rep. 2024 Jan 20;14(1):1772. doi: 10.1038/s41598-024-52206-0.
8
Analysis of Efficacy and Safety of Small-Volume-Plasma Artificial Liver Model in the Treatment of Acute-On-Chronic Liver Failure.小容量血浆置换人工肝模型治疗慢加急性肝衰竭的疗效及安全性分析。
Physiol Res. 2023 Dec 31;72(6):767-782. doi: 10.33549/physiolres.935158.
9
The clinical courses of HBV-related acute-on-chronic liver failure and a multi-state model to predict disease evolution.HBV 相关慢加急性肝衰竭的临床病程和预测疾病演变的多状态模型。
Hepatol Commun. 2024 Jan 5;8(1). doi: 10.1097/HC9.0000000000000354. eCollection 2024 Jan 1.
10
A multi-subgroup predictive model based on clinical parameters and laboratory biomarkers to predict in-hospital outcomes of plasma exchange-centered artificial liver treatment in patients with hepatitis B virus-related acute-on-chronic liver failure.基于临床参数和实验室生物标志物的多亚组预测模型,预测乙型肝炎病毒相关慢加急性肝衰竭患者血浆置换为中心的人工肝治疗的住院结局。
Front Cell Infect Microbiol. 2023 Mar 21;13:1107351. doi: 10.3389/fcimb.2023.1107351. eCollection 2023.